Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects.

NCT00345202 is registered in ClinicalTrials.gov with Regional Hospital Holstebro as lead sponsor.

NCT NCT00345202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00345202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects.
Lead sponsor
Regional Hospital Holstebro
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2004
Completion date
February 28, 2005
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy